Tetsuro Shimakami

2.9k total citations
89 papers, 2.0k citations indexed

About

Tetsuro Shimakami is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Tetsuro Shimakami has authored 89 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Hepatology, 56 papers in Epidemiology and 25 papers in Molecular Biology. Recurrent topics in Tetsuro Shimakami's work include Hepatitis C virus research (45 papers), Hepatitis B Virus Studies (34 papers) and Liver Disease Diagnosis and Treatment (30 papers). Tetsuro Shimakami is often cited by papers focused on Hepatitis C virus research (45 papers), Hepatitis B Virus Studies (34 papers) and Liver Disease Diagnosis and Treatment (30 papers). Tetsuro Shimakami collaborates with scholars based in Japan, United States and Germany. Tetsuro Shimakami's co-authors include Stanley M. Lemon, Masao Honda, Daisuke Yamane, Taro Yamashita, Yoshio Sakai, Shuichi Kaneko, Takayoshi Shirasaki, Rohit K. Jangra, Seishi Murakami and Carolyn Spaniel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Tetsuro Shimakami

80 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuro Shimakami Japan 25 999 906 798 578 182 89 2.0k
Takahiro Masaki Japan 22 641 0.6× 943 1.0× 775 1.0× 303 0.5× 146 0.8× 59 1.7k
Eiji Kakazu Japan 24 781 0.8× 692 0.8× 927 1.2× 371 0.6× 169 0.9× 75 2.0k
Vikas Verma India 17 831 0.8× 519 0.6× 855 1.1× 448 0.8× 91 0.5× 47 1.8k
Yasuteru Kondo Japan 29 704 0.7× 1.1k 1.2× 1.1k 1.4× 393 0.7× 184 1.0× 97 2.5k
Ursula Andréo United States 14 568 0.6× 377 0.4× 482 0.6× 426 0.7× 159 0.9× 18 1.4k
Xu Lin China 25 798 0.8× 286 0.3× 552 0.7× 295 0.5× 92 0.5× 81 1.6k
Reina Sasaki Japan 18 401 0.4× 547 0.6× 439 0.6× 251 0.4× 144 0.8× 87 1.2k
Young‐Hwa Chung South Korea 33 660 0.7× 1.6k 1.7× 1.4k 1.8× 302 0.5× 211 1.2× 86 2.8k
Diego Flichman Argentina 18 391 0.4× 600 0.7× 1.1k 1.4× 325 0.6× 150 0.8× 71 1.5k
Shingo Nakamoto Japan 23 245 0.2× 1.0k 1.2× 844 1.1× 138 0.2× 222 1.2× 107 1.6k

Countries citing papers authored by Tetsuro Shimakami

Since Specialization
Citations

This map shows the geographic impact of Tetsuro Shimakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuro Shimakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuro Shimakami more than expected).

Fields of papers citing papers by Tetsuro Shimakami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuro Shimakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuro Shimakami. The network helps show where Tetsuro Shimakami may publish in the future.

Co-authorship network of co-authors of Tetsuro Shimakami

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuro Shimakami. A scholar is included among the top collaborators of Tetsuro Shimakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuro Shimakami. Tetsuro Shimakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Terashima, Takeshi, Kouki Nio, Naohiko Koshikawa, et al.. (2025). Serum laminin γ2 monomer as a novel diagnostic and prognostic marker for pancreatic ductal adenocarcinoma. PubMed. 3(1). 2–2. 1 indexed citations
2.
Terashima, Takeshi, Makoto Yamamoto, Tadashi Toyama, et al.. (2025). The efficacy and safety of adding hepatic arterial infusion chemotherapy using cisplatin to lenvatinib for advanced hepatocellular carcinoma. Hepatology Research. 55(7). 1026–1037.
3.
Terashima, Takeshi, Tatsuya Yamashita, Kuniaki Arai, et al.. (2024). Comprehensive genomic profiling for advanced hepatocellular carcinoma in clinical practice. Hepatology International. 19(1). 212–221. 3 indexed citations
4.
Kawaguchi, Kazunori, Tetsuro Shimakami, Hidetoshi Nakagawa, et al.. (2024). Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapy. PLoS ONE. 19(5). e0299424–e0299424.
5.
Nio, Kouki, Tetsuro Shimakami, Kazuyuki Kuroki, et al.. (2023). Super-Resolution Microscopy Analysis of Hepatitis B Viral cccDNA and Host Factors. Viruses. 15(5). 1178–1178. 5 indexed citations
6.
Yamamoto, Makoto, Takeshi Terashima, Tatsuya Yamashita, et al.. (2023). Successful second‐line treatment with cabozantinib for hepatocellular carcinoma harboring cytoplasmic mesenchymal–epithelial transition factor amplification. Hepatology Research. 54(3). 315–319. 2 indexed citations
7.
Nishikawa, Masashi, Hikari Okada, Kazunori Kawaguchi, et al.. (2023). Identification of a Transmembrane Protein Involved in Shear Stress Signaling and Hepatocarcinogenesis After a Sustained Virological Response to Hepatitis C Virus. Cellular and Molecular Gastroenterology and Hepatology. 16(2). 263–286. 4 indexed citations
8.
Li, Ru, Hikari Okada, Taro Yamashita, et al.. (2022). FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition. International Journal of Molecular Sciences. 23(15). 8305–8305. 10 indexed citations
9.
10.
Terashima, Takeshi, Tatsuya Yamashita, Tatsuya Yamashita, et al.. (2020). Safety and efficacy of sorafenib followed by regorafenib or lenvatinib in patients with hepatocellular carcinoma. Hepatology Research. 51(2). 190–200. 8 indexed citations
11.
Yamashita, Taro, Hikari Okada, Kouki Nio, et al.. (2020). Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular Carcinoma. Cellular and Molecular Gastroenterology and Hepatology. 10(2). 269–285. 12 indexed citations
12.
Mizukoshi, Eishiro, Takeshi Terashima, Noriho Iida, et al.. (2020). A novel α-fetoprotein-derived helper T-lymphocyte epitope with strong immunogenicity in patients with hepatocellular carcinoma. Scientific Reports. 10(1). 4021–4021. 7 indexed citations
13.
Shirasaki, Takayoshi, Masao Honda, Tetsuro Shimakami, et al.. (2018). Peretinoin, an Acyclic Retinoid, Inhibits Hepatitis B Virus Replication by Suppressing Sphingosine Metabolic Pathway In Vitro. International Journal of Molecular Sciences. 19(2). 108–108. 7 indexed citations
14.
15.
Kawaguchi, Kazunori, Masao Honda, Hajime Ohta, et al.. (2017). Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein predicts hepatocellular carcinoma incidence and recurrence in nucleos(t)ide analogue therapy for chronic hepatitis B. Journal of Gastroenterology. 53(6). 740–751. 20 indexed citations
16.
Welsch, Christoph, Tetsuro Shimakami, Christoph Hartmann, et al.. (2011). Peptidomimetic Escape Mechanisms Arise via Genetic Diversity in the Ligand-Binding Site of the Hepatitis C Virus NS3/4A Serine Protease. Gastroenterology. 142(3). 654–663. 15 indexed citations
17.
Shirasaki, Takayoshi, Masao Honda, Kazunori Kawaguchi, et al.. (2010). HCV-INFECTION-SPECIFIC MIRNAS CAPABLE OF REGULATING HCV REPLICATION. Hepatology. 52(4). 821–822. 1 indexed citations
18.
Honda, Masao, Mikiko Nakamura, Akito Sakai, et al.. (2010). Differential interferon signaling in liver lobule and portal area cells under treatment for chronic hepatitis C. Journal of Hepatology. 53(5). 817–826. 18 indexed citations
19.
Shimakami, Tetsuro, Robert E. Lanford, & Stanley M. Lemon. (2009). Hepatitis C: recent successes and continuing challenges in the development of improved treatment modalities. Current Opinion in Pharmacology. 9(5). 537–544. 35 indexed citations
20.
Shimakami, Tetsuro, Tatsuya Yamashita, Yoshio Sakai, et al.. (2007). A case of primary biliary cirrhosis with progressive jaundice due to Basedow's disease. Kanzo. 48(9). 452–457.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takahiro Masaki Breakdown of academic impact, for papers by Eiji Kakazu Breakdown of academic impact, for papers by Vikas Verma Breakdown of academic impact, for papers by Yasuteru Kondo Breakdown of academic impact, for papers by Ursula Andréo Breakdown of academic impact, for papers by Xu Lin Breakdown of academic impact, for papers by Reina Sasaki Breakdown of academic impact, for papers by Young‐Hwa Chung Breakdown of academic impact, for papers by Diego Flichman Breakdown of academic impact, for papers by Shingo Nakamoto
Rankless by CCL
2026